FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3022734905> ?p ?o ?g. }

• W3022734905 endingPage "9" @default.
• W3022734905 startingPage "1" @default.
• W3022734905 abstract "Body fluids often contain freely circulating nucleic acids, many of which can be exploited as noninvasive tools for the diagnosis of cancer as well as for clinical prognostication. Identifying microRNAs (miRNAs) in subjects’ blood with various malignancies means that they can serve as novel biomarkers for prostate cancer (PCa) diagnosis. This study analyzed serum-circulating miRNAs as a noninvasive biomarker in subjects with PCa and subjects with benign prostatic hyperplasia (BPH). In total, 31 PCa subjects and 31 BPH subjects were included, with the BPH group serving as the control group. RT-qPCR was used to quantify the levels of 10 miRNAs, which included miR-18a, miR-34a, miR-106b, miR-183, miR-200a, miR-301a, miR-141, miR-182, miR-200b, and miR-375 in serum. Statistical tests were used to assess the relationship between the levels of miRNAs and the clinicopathological data. A significant increase was observed in the relative expression ratios of miR-141, miR-182, miR-200b, and miR-375 (1.89-, 2.09-, 2.41-, and 2.27-folds, respectively) in the PCa group when compared to the BPH group. Based on the receiver operating characteristic (ROC) analysis, the largest area under the curve (AUC), 0.923, was associated with the miR-200b group, indicating effective diagnostic properties for this biomarker. A correlation was observed between total prostate-specific antigen (TPSA) and the relative levels of miR-141, miR-182, miR-200b, and miR-375. The Gleason score and the miR-200b expression level were also correlated. These results are consistent with previous studies regarding the possibility of differentiating between PCa subjects and healthy controls based on the detection of miRNA. The findings attest to a distinctive expression profile of miRNA that is detectable in the blood of PCa subjects, thereby confirming the role of miRNAs as diagnostic biomarkers for PCa." @default.
• W3022734905 created "2020-05-13" @default.
• W3022734905 creator A5011183246 @default.
• W3022734905 creator A5029811844 @default.
• W3022734905 creator A5049798132 @default.
• W3022734905 creator A5063922884 @default.
• W3022734905 creator A5077459413 @default.
• W3022734905 date "2020-05-08" @default.
• W3022734905 modified "2023-10-11" @default.
• W3022734905 title "Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia" @default.
• W3022734905 cites W1963691340 @default.
• W3022734905 cites W1963853602 @default.
• W3022734905 cites W1964453634 @default.
• W3022734905 cites W1979587260 @default.
• W3022734905 cites W1995405710 @default.
• W3022734905 cites W1998449659 @default.
• W3022734905 cites W2002690800 @default.
• W3022734905 cites W2007800006 @default.
• W3022734905 cites W2014007818 @default.
• W3022734905 cites W2022667041 @default.
• W3022734905 cites W2033479946 @default.
• W3022734905 cites W2040972376 @default.
• W3022734905 cites W2043921617 @default.
• W3022734905 cites W2048603557 @default.
• W3022734905 cites W2069660208 @default.
• W3022734905 cites W2088246882 @default.
• W3022734905 cites W2089312526 @default.
• W3022734905 cites W2095761465 @default.
• W3022734905 cites W2109046819 @default.
• W3022734905 cites W2115093090 @default.
• W3022734905 cites W2126934643 @default.
• W3022734905 cites W2132528779 @default.
• W3022734905 cites W2154386365 @default.
• W3022734905 cites W2160236294 @default.
• W3022734905 cites W2191329868 @default.
• W3022734905 cites W2235442421 @default.
• W3022734905 cites W2403990825 @default.
• W3022734905 cites W2412461927 @default.
• W3022734905 cites W2560292269 @default.
• W3022734905 cites W2755834791 @default.
• W3022734905 cites W2765503564 @default.
• W3022734905 cites W2766671845 @default.
• W3022734905 cites W2791547005 @default.
• W3022734905 cites W2791700124 @default.
• W3022734905 cites W2800738672 @default.
• W3022734905 cites W2883343838 @default.
• W3022734905 cites W2889646458 @default.
• W3022734905 cites W2904952494 @default.
• W3022734905 cites W2922719419 @default.
• W3022734905 cites W2940812978 @default.
• W3022734905 cites W2970448893 @default.
• W3022734905 cites W2970563913 @default.
• W3022734905 doi "https://doi.org/10.1155/2020/5873056" @default.
• W3022734905 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7230987" @default.
• W3022734905 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32455140" @default.
• W3022734905 hasPublicationYear "2020" @default.
• W3022734905 type Work @default.
• W3022734905 sameAs 3022734905 @default.
• W3022734905 citedByCount "18" @default.
• W3022734905 countsByYear W30227349052021 @default.
• W3022734905 countsByYear W30227349052022 @default.
• W3022734905 countsByYear W30227349052023 @default.
• W3022734905 crossrefType "journal-article" @default.
• W3022734905 hasAuthorship W3022734905A5011183246 @default.
• W3022734905 hasAuthorship W3022734905A5029811844 @default.
• W3022734905 hasAuthorship W3022734905A5049798132 @default.
• W3022734905 hasAuthorship W3022734905A5063922884 @default.
• W3022734905 hasAuthorship W3022734905A5077459413 @default.
• W3022734905 hasBestOaLocation W30227349051 @default.
• W3022734905 hasConcept C104317684 @default.
• W3022734905 hasConcept C121608353 @default.
• W3022734905 hasConcept C126322002 @default.
• W3022734905 hasConcept C126894567 @default.
• W3022734905 hasConcept C142724271 @default.
• W3022734905 hasConcept C143998085 @default.
• W3022734905 hasConcept C145059251 @default.
• W3022734905 hasConcept C2776235491 @default.
• W3022734905 hasConcept C2777562237 @default.
• W3022734905 hasConcept C2780192828 @default.
• W3022734905 hasConcept C2781197716 @default.
• W3022734905 hasConcept C2781406297 @default.
• W3022734905 hasConcept C3017616150 @default.
• W3022734905 hasConcept C55493867 @default.
• W3022734905 hasConcept C58471807 @default.
• W3022734905 hasConcept C71924100 @default.
• W3022734905 hasConcept C76318530 @default.
• W3022734905 hasConcept C86803240 @default.
• W3022734905 hasConcept C87874733 @default.
• W3022734905 hasConceptScore W3022734905C104317684 @default.
• W3022734905 hasConceptScore W3022734905C121608353 @default.
• W3022734905 hasConceptScore W3022734905C126322002 @default.
• W3022734905 hasConceptScore W3022734905C126894567 @default.
• W3022734905 hasConceptScore W3022734905C142724271 @default.
• W3022734905 hasConceptScore W3022734905C143998085 @default.
• W3022734905 hasConceptScore W3022734905C145059251 @default.
• W3022734905 hasConceptScore W3022734905C2776235491 @default.
• W3022734905 hasConceptScore W3022734905C2777562237 @default.
• W3022734905 hasConceptScore W3022734905C2780192828 @default.

• next